According to a new market report published by Lucintel,
the future of the global cardiovascular device market looks good with
opportunities in public and private hospitals. The global cardiovascular device
market is expected to reach an estimated $69.3 billion by 2022, and it is
forecast to grow at a CAGR of 4.3% from 2017 to 2022. The major drivers for
market growth are growing demand for minimally invasive surgery, increasing
healthcare expenditure, and growing geriatric population.
The cardiac rhythm
management (CRM), interventional cardiac devices, peripheral vascular devices, cardiac
assist devices, structural heart devices, cardiovascular surgery, electrophysiology,
and diagnostic & monitoring devices are the main branches of global
cardiovascular device market. On the basis of comprehensive research, Lucintel forecasts that the structural heart device, electrophysiology,
cardiac assist device, and diagnostic & monitoring device segments are
expected to show above average growth during the forecast period.
Within the global cardiovascular device
market, the CRM segment is expected to remain the largest segment. Increasing
use of defibrillators mainly due to its cost effectiveness and safety is
expected to result in significant growth of the CRM market.
By
device type, the global cardiovascular device market is segmented into
pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, ECG,
event monitor, and others. The defibrillator is the largest market mainly due
to the development of technologically advanced defibrillators and rapid growth
in the aging population with high risk of cardiovascular diseases.
North America
is expected to remain the largest market during the forecast period mainly due
to presence of a large size target patient pool coupled with high adoption rate
for advanced treatments in this region.
APAC is expected to witness the highest growth over the forecast period due
to growing health awareness, improved healthcare infrastructure along with an increasing spending capacity
of the population in this region.
Emerging
trends which have a direct impact on the dynamics of the industry include increasing
demand of portable heart monitoring devices, rising adoption of transcatheter
aortic valve replacement (TAVR) procedure, and increasing use of bioresorbable
stents. Medtronic Public Limited Company, Boston Scientific Corporation, Abbott
Laboratories, Edwards Lifesciences Corporation, and Johnson & Johnson are
among the major suppliers of cardiovascular devices.
Lucintel, a
leading global strategic consulting and market research firm, has analyzed
growth opportunities in the global cardiovascular device market by type, device,
and region, and has compiled a comprehensive research report entitled “Growth
Opportunities in the Global Cardiovascular Device Market 2017-2022: Trends,
Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst
for growth strategy by providing comprehensive data and analysis on trends, key
drivers, and directions. The study includes a forecast for the global cardiovascular
device market by type, device, and
region, as follows:
By Type [Value ($ Million) from 2011 to 2022]:
· Cardiac
Rhythm Management
· Interventional
Cardiac Devices
· Peripheral
Vascular Devices
· Cardiac
Assist Devices
· Structural
Heart Devices
· Cardiovascular
Surgery
· Electrophysiology
·
Diagnostic & Monitoring Devices
By Device
[Value ($ Million) from 2011 to 2022]:
· Pacemaker
· Defibrillator
· Stent
· Cardiac
Catheter
· Guidewire
· Heart Valve
· ECG
· Event Monitor
·
Others
By Region [Value
($ Million) from 2011 to 2022]:
· North America
− United States
· Europe
− Germany
− France
− United Kingdom
− Italy
− Spain
· APAC
− Japan
− China
− India
· ROW
− Brazil
This 197-page research report will enable you to make confident business decisions in this
globally competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or helpdesk@lucintel.com. Lucintel offerings include medical market analysis,
medical market research, commercial due diligence report, business strategy consulting and
market research reports online.
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity analysis, growth consulting, M&A, and due diligence
services to executives and key decision-makers in a variety of industries. For
further information, visit www.lucintel.com.
This report addresses the following key
questions:
Q. 1. What are some of the most promising, high-growth
opportunities for global cardiovascular device market by type, which includes cardiac
rhythm management, interventional cardiac devices, peripheral vascular devices,
cardiac assist devices, structural heart devices, cardiovascular surgery, electrophysiology,
and diagnostic & monitoring devices, by device (pacemaker, defibrillator,
stent, cardiac catheter, guidewire, heart valve, ECG, event monitor, and
others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q. 2. Which products segments
will grow at a faster pace and why?
Q. 3. Which region will grow at a faster pace
and why?
Q.4. What are the key factors affecting
market dynamics? What are the drivers, challenges, and business risks in this market?
Q.5. What are the business risks and competitive
threats in this market?
Q.6. What are the emerging trends in this
market and the reasons behind them?
Q.7. What are some of the changing demands of
customers in the market?
Q.8. What are the new developments in the
market and which companies are leading these developments?
Q.9. Who are the major players in this
market? What strategic initiatives are being taken by key companies for
business growth?
Q.10. What are some of the competing products
in this market and how big of a threat do they pose for loss of market share by
product substitution?
Q. 11. What M&A activity has occurred in
the last 5 years?
No comments:
Post a Comment